The results of a Kruskal Wallis test comparing the various adherence metrics, during increasing and decreasing periods, by pandemic phase are shown as the title of each graph: The... by Barry Smyth (10826056)

IpaH9.8 mutants display decreased activity to degrade the GBPs. by Chenggong Ji (6858425)

Opinion distributions and mean shadow ban strength versus time under shadow banning control policies for different objective functions on a path network. by Yen-Shao Chen (18264587)

Subjects:

Fig 1 - by Gláucia Helena Fernandes Seixas (5866511)

A model for elucidating the transovarial transmission of <i>N</i>. <i>bombycis</i>. by Chunxia Wang (766713)

The nsP4-Q192L and C483Y mutations decrease the 4′-FlU sensitivity of both replication and transcription. by Peiqi Yin (6533747)

Decreased recovery times were observed after repeated handling and anesthesia sessions. by Lingzhi Wang (114519)

Opinion distributions and mean shadow ban strength versus time under shadow banning control policies for different objectives on a stochastic block model network. by Yen-Shao Chen (18264587)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Subjects:

Foldases and holdases each decrease the level of unfolded protein. by Adam MR de Graff (9767829)

Decreased UFA/SFA ratio induces cytosolic chaperones. by Dongyeop Lee (108880)

Mitochondrial fusion event (see Fig 7A). by Cynthia Alsayyah (18452506)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Subjects:

Number of viruses detected by virological confirmation in ARI consultation. by Titouan Launay (11547468)

Fzo1 is a natural PerMit tether in WT cells. by Cynthia Alsayyah (18452506)

Subjects:

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Subjects:

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Subjects:

S1 Dataset - by Lina Yu (1731598)

“…<div><p>Though numerous empirical and theoretical studies have been conducted on the determinants and effects of executive compensation, empirical evidence regarding the bargaining effect on the monetary compensation decisions of executives, especially in a large emerging economy such as China, remains scarce. …”